Released on = April 30, 2007, 5:07 am

Press Release Author = Bharat Book Bureau

Industry = Pharmaceuticals

Press Release Summary = Will the economic growth in new Asian markets allow you to
offset global problems? With the Japan market slow and stagnant what other countries
in the region offer you the greatest opportunities and how can you succeed in them.
This report tells you.


Press Release Body = Will the economic growth in new Asian markets allow you to
offset global problems? With the Japan market slow and stagnant what other countries
in the region offer you the greatest opportunities and how can you succeed in them.
This report tells you.

Asian Developing Markets for Pharmaceuticals, 2006-2011 delivers to you unique
prospects for the largest developing pharmaceutical market - Asia.

This report predicts that all the leading developing markets will exhibit strong
growth from 2006-2011. Rapid economic growth and large, under-served populations
will drive that expansion in pharmaceutical revenues. There will be significant
growth in sales of both branded and generic drugs through increasing demand from
both public and private healthcare sectors.

This unique report concentrates on the following themes :

Forecasts of sales revenues and growth rates for leading developing markets in Asia,
from 2006-2011
Drivers and opportunities in the markets you should be working in
Restraints and threats in those markets
Discussion of key players and important therapeutic areas
Discussion of relevant regulatory, societal and economic issues
Comparison of the prospects for revenue generation in Asia, Latin America and
Central/Eastern Europe, with overall forecasts for those regions
Who you should be working with and why
Why you should buy this report:

To receive a comprehensive analysis of the prospects for developing regional and
national markets for pharmaceuticals in Asia from 2006-2011, as well as comparative
data for other developing regions
To discover predicted revenues, growth rates and other key metrics for Asian
developing markets from 2006-2011
To determine the forces that influence pharmaceutical sales in the Asian developing
markets:
Competitive characteristics of the market, both at - national and regional level
- Regulatory, technological, societal and political issues
- Drivers and restraints
- Strengths, weaknesses, opportunities and threats

The dominant pharmaceutical markets of North America, Western Europe and Japan
currently account for approximately 85% of revenues for prescription drugs. However,
there is concern about the relatively low growth of those established markets in
recent years. Consequently, international pharmaceutical companies are very
interested in raising their profile in the developing markets of Asia.

You cannot afford to ignore this expanding market. A small investment today will be
the catalyst of a great return for your company tomorrow.

Unique benefits to you when you order this report
- Full searchable report when you buy the company or corporate editions
- Immediate access through our exclusive Reading Room
- You can access your report whichever country you are in without using hard drive
space
- Primary research throughout. You will not find this information anywhere else
- Report stored in your reading room for ever
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables

Additional Information

Organisations Listed :

Abbott Laboratories
Abdi Ibrahim
Ablomed
Actavis
Adamed
Akrikhin
Alkem
Alpharma
Apex International Clinical Research
Armstrong
AstraZeneca
Bagó
Barr Pharmaceuticals
Bayer
Berlin-Chemie
Bristol-Myers Squibb
Bryntsalov A
Cadila Healthcare
Choong Wae
Cipla
Dae Woong
Dexa Medica
Dong A
Dr Reddy's Laboratories
Eczacibasi
Egis
Elea
Eli Lilly
F. Hoffman-La Roche
Fresenius
Gador
Gedeon Richter
Genovate Biotec
Geven
GlaxoSmithKline
Guangzhou Tainxin
Han Mi
Heilongjiang Haerbin Pharmaceutical
Hexal
Hoechst Marion Roussel
ICON
II Dong
Immunopreparat
Interbat
Ivax Pharmaceuticals
Jiangsu Lianyungang Hengrui
Johnson & Johnson
Kalbe Farma
Krka
KRKA D.D.
Lek
Menarini
Merck & Co
Merck KGaA
Merck Sharp Dohme
Moskhimpharmpreparaty
MSD Korea
Mylan Laboratories
Nicholas Piramal
Nizpharm
Novartis
Novo Nordisk
Nycomed
Omnicare CR
Otechestvennye Lekarstiva
Otsuka Pharmaceutical
Pascual Laboratories
Perlican
Pfizer
PHARM-CENTR
Pharmstandart
Phoenix
Pliva
Polfa Kutno
Polfa Warszawa
Polpharma SA
Protech Pharmaservice
Quintiles
Ranbaxy Laboratories
Roche
Roemmers
Sanbe Farma
Sandoz
Sanofi-Aventis
Schering Plough
Schwarz Pharmaceutical
Servier Pharmaceuticals
Siam Pharma
Soul-Pattinson
Sun Pharmaceutical Industries
Teva Pharmaceutical
Trans-India Acquisition Corporation
Unichem
United Laboratories
Veropharm
Virginia CRO
VIRION
Watson Pharmaceuticals
Wockhardt
Wyeth
Yangzijiang Pharmaceutical
Yuhan Company
Yung Shin Pharmaceutical Industries
Zentiva
Zydus Cadila

For more information, Please visit : http://www.bharatbook.com/detail.asp?id

Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium, Navi Mumbai - 400 614, India.
Ph. : +91-(022)-2757 8668 or +91-(022)-2757 9131
email : bharatbook@gmail.com